Delivery Order SPE2DB22D2005-SPE2DB24FJRH0

Award Date 8/14/24
Potential Completion Date 8/15/24
Potential Value $5.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a total ceiling value of $17,123.97 and a performance period through May 2, 2025. It is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,761.49 firm fixed-price contract is for the delivery of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp is also the holder of a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA) to provide RABAVERT Rabies Vaccine with Diluents. The $46,385.15 firm fixed-price contract has an ultimate completion date of May 30, 2024. This delivery order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office Division. The $1,930.30 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluent. The order has a completion date of July 19, 2024. Amerisourcebergen is a major pharmaceutical distributor that provides a wide range of medical products and supplies to federal agencies, including the military. The company holds several Indefinite Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,493.00 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The delivery order does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,239.50, is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of February 26, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The contract has a firm fixed price of $13,213.96 and a completion date of February 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as the primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,479.00 firm fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. The contract has an ultimate completion date of June 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,651.50 firm fixed-price delivery order is for the supply of RABAVERT rabies vaccine with diluents, with a completion date of November 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
This is a $9,057.42 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, a critical medical product used in the treatment of rabies exposure. The delivery order has a completion date of September 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of medical supplies and medications to federal agencies,...
  • SPE2DB22D2005
    Indefinite Delivery Contract
  • SPE2DB22D2005-SPE2DB24FJRH0
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The $5,790.90 firm-fixed-price contract is for the supply of RABAVERT rabies vaccine with diluents. This award is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is expected to be completed by August 15, 2024. As a major pharmaceutical distributor, AmerisourceBergen leverages its extensive supply chain network to provide critical medical commodities to various federal agencies and healthcare programs.

Generated 11/13/24, 9:28 AM